Упрощенная HTML-версия
Syndrome Coronavirus / E. N. Van den Brink [et al.]
II
J. Virol. - 2005. - Vol. 79. -
P. 1635-1644.
409. Monocytic Ehrlichia in Ixodes persulcatus ticks from Perm, Russia / M.D. Ravin
[et al.] // Lancet - 1999. - Vol. 353, № 9154 -P. 722-723.
410. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding
canyon / T. J. Smith [et al.] // Nature. - 1996. - Vol. 383. - P. 350-354.
411. Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a
VZV patient recombinant antibody library / L. Kausmally [et al.] // J. Gen. Virol. -
2004. - Vol. 85. - P. 3493-3500.
412. NeutralizinghumanFab fragments againstmeasles virus recovered byphage display /
C. de Carvalho Nicacio [et al.] // J. Virol. - 2002. - Vol. 76. - P. 251-258.
413. Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage
display / S. J. Kim [et al.] // Virology. - 2004. - Vol. 318. - P. 598-607.
414. Neonatal enterovirus infection: virology, serology, and effects of intravenous
immune globulin / M. J. Abzug [et al.] // Clin. Infect. Dis. - 1995. - Vol. 20. -
P. 1201-1206.
415. Neutralizing Antibodies Protect against Lethal Flavivirus Challenge but Allow for
the Development of Active Humoral Immunity to a Nonstructural Virus Protein /
Th. R. Kreii [et al.] // J Virol. - 1998. - Vol. 72, № 4. - P. 3076-3081.
416. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon
secretion from the host cell / A. J. Crooks [et al.] // J. Gen. Virol. - 1994. -
Vol. 75 .-P . 3453-3460.
417. Ogilvie, М. M. Antiviral prophylaxis and treatment in chickenpox, a review
prepared for the UK Advisory Group on chickenpox on behalf o f the British
Society for the Study of Infection / М. M. Ogilvie // J. Infect. - 1998. - Vol. 36,
(Suppl. 1 ) . - P. 31-38.
418. Outlaw, М. C. IgG neutralization of type A influenza viruses and the inhibition of
the endosomal fusion stage of the infectious pathway in BHK cells / М. C. Outlaw,
N. J. Dimmock // Virology. - 1993. - Vol. 195. - P. 413-421.
419. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces
hospitalization from respiratory syncytial virus infection in high-risk infants /
The Impact-RSV Study Group // Pediatrics. - 1998. - Vol. 102. - P. 531-537.
420. Parisien, J. P. STAT2 Acts as a Host Range Determinant for Species-Specific
Paramixovirus Interferon Antagonism and Simian Virus 5 Replication /
J. P. Parisien, J. F. Lau, С. M. Horvath // J. Virol. - 2002. - Vol. 76. -
P. 6435-6441.
421. Passive immunization during pregnancy for congenital cytomegalovirus infection
/ G. Nigro, S. P. Adler, R. La Torre, A.M. Best, the Congenital Cytomegalovirus
Collaborating Group // The New England Journal of Medicine. - 2005. - 353. -
P. 1350-1362.
422. Passive immunization o f Ebola virus-infected cynomolgus monkeys with
immunoglobulin from hyperimmune horses / P. B. Jahrling [et al.] // Arch.
Virol. - 1996 .-№ 11(Suppl.). - P. 135-140.
423. Passive immunization reduces immunity that results from simultaneous active
immunization against tick-borne encephalitis virus in a mouse model / T. R. Kreil
[et al.] // Vaccine. - 1998. - Vol. 16. - P. 955-959.
424. Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb)
226